Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1

doi:10.4239/wjd.v14.i2.110

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3447)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

150

WORD

HTML

1289

Figures (1-4)

395

Tables (1-3)

373

Sum=2228

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

170

Download

407

Sum=577

Publishing Process of This Article

Item

Count

Browse

188

Download

454

Sum=642

Feb 15, 2023 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Feb 15, 2023; 14(2): 110-119
Published online Feb 15, 2023. doi: 10.4239/wjd.v14.i2.110

Table 1 Comparison of body weight and heart weight index of rats in each group (mean ± SD)

Group	Weight	Heart weight index
N	381 ± 22.5	2.58 ± 0.28
M	476.2 ± 27.5^a	4.46 ± 0.31^a
LL	451.5 ± 10.4^a^b	3.98 ± 0.26^a^b
HL	430.1 ± 13.5^a^b^c	3.03 ± 0.33^a^b^c

^aP < 0.05, compared with group N.

^bP < 0.05, compared with group M.

^cP < 0.05, compared with group LL.

N: Normal control; M: Model; HL: High-dose liraglutide; LL: Low-dose liraglutide.

Table 2 Comparison of blood glucose and blood lipids of rats in each group (mean ± SD)

Group	FBG	TG	TC	LDL	HDL	LP
N	5.7 ± 0.9	1.2 ± 0.28	1.73 ± 0.44	0.66 ± 0.25	1.5 ± 0.57	298 ± 41
M	25.9 ± 2.8^a	2.84 ± 0.56^a	4.27 ± 0.56^a	5.49 ± 2.37^a	1.05 ± 0.19	667 ± 79^a
LL	20.9 ± 1.1^a^b	2.24 ± 0.52^a^b	3.32 ± 0.7^a^b	3.56 ± 0.73^a^b	1.1 ± 0.2	549 ± 45^a^b
HL	18.9 ± 1.3^a^b^c	1.67 ± 0.39^a^b^c	2.66 ± 0.76^a^b^c	2.06 ± 0.77^a^b^c	1.42 ± 0.64	448 ± 130^a^b^c

^aP < 0.05, compared with group N.

^bP < 0.05, compared with group M.

^cP < 0.05, compared with group LL.

N: Normal control; M: Model; HL: High-dose liraglutide; LL: Low-dose liraglutide. FBG: Fasting blood glucose; TG: Triglyceride; TC: Total cholesterol; LDL: Low density lipoprotein; HDL: High density lipoprotein; LP: Lipoprotein.

Table 3 Expression of polyadenosine diphosphate-ribose polymerase-1 in myocardial tissue of rats in each group (mean ± SD)

Group	Number	PARP-1
N	8	10.92 ± 3.59
M	8	58.12 ± 5.31^a
LL	8	42.83 ± 1.14^a^b
HL	8	23.61 ± 0.92^a^b^c

^aP < 0.05, compared with group N.

^bP < 0.05, compared with group M.

^cP < 0.05, compared with group LL.

PARP-1: Polyadenosine diphosphate-ribose polymerase-1; N: Normal control; M: Model; HL: High-dose liraglutide; LL: Low-dose liraglutide.

Citation: Xue DD, Zhang X, Li DW, Yang YL, Liu JJ. Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1. World J Diabetes 2023; 14(2): 110-119
URL: https://www.wjgnet.com/1948-9358/full/v14/i2/110.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i2.110